Salvage Surgery for Bronchopleural Fistula Due to Durvalumab and Chemoradiation
- 1 September 2022
- journal article
- editorial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 114 (3) , e185-e187
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Risk of Pneumonitis in Patients With Stage III Non-Small Cell Lung Cancer Treated With Definitive Chemo-RT and Durvalumab ConsolidationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
- Salvage pulmonary resection in stages IIIb–IV lung cancer after treatment with immune checkpoint inhibitors case series and literature reviewJournal of Surgical Oncology, 2021
- Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomesEuropean Journal of Cardio-Thoracic Surgery, 2021
- Secondary Pneumothorax During Immunotherapy in two Patients with Metastatic Solid Tumors; a New EntityImmunotherapy, 2021
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerNew England Journal of Medicine, 2017